Generer rapport
Anicura Aps
Marielundvej 46E, 1 th, 2730 Herlev, CVR 34897778
Branche:
Dyrlægers aktiviteter [750000]
Virksomhedsform
Anpartsselskab
Etableret
2012
Størrelse
Store
Ansatte
427
Omsætning
435
MDKK
Bruttofortj.
229
MDKK
Primært resultat (EBIT)
-27.638.000
DKK
Årets resultat
3.834.000
DKK
Egenkapital
271
MDKK
annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
13/358
"Top 10%"
Rang i Danmark
25.625/350.373
"Top 10%"
Direktion top 3
Bestyrelse top 3
Fabrice Charles Louis Ribourg 4 | Bestyrelsesformand |
Chelina Natasha Klehr Haaning 5 | Næstformand |
Alexandra Cole Koprowski 3 | Bestyrelsesmedlem |
Legale ejere top 3
100% | AniCura AB | SE |
Tegningsregler
Selskabet tegnes af 2 bestyrelsesmedlemmer i forening eller 1 bestyrelsesmedlem i forening med 1 direktør eller af den samlede bestyrelse.
Stamoplysninger baseret på CVR
Navn | Anicura Aps |
Binavne | Anicura Aarhus Dyrehospital Aps, Anicura Centrum Dyrehospital Aps, Anicura Dyrehospitalet City Syd Aps, Anicura Dyreklinikken Nørresundby Aps, Anicura Familiedyrlægerne Aps, Anicura Frederiksværk Dyrehospital Aps, Anicura Gistrup Dyrehospital Aps, Anicura Hjørring Dyrehospital Aps, Anicura Holbæk Dyrehospital Aps, Anicura Københavns Dyrehospital Aps, Anicura Odense Dyrehospital Aps, Anicura Online Aps, Anicura Rynkeby Dyreklinik Aps, Anicura Shop Aps, Anicura Skovlunde Dyrehospital Aps, Anicura Sydvet Dyrehospitaler Aps, Anicura Tanddyreklinikken Aps, Anicura Tanddyreklinikken _ Aps, Anicura Vangede Dyreklinik Aps, Anicura Varde Dyrehospital Aps, Anicura Østergaards Dyrehospital Aps, Dyrehospitalet City Syd Aps, Dyrehospitalet Hobrovej Aps, Dyrehospitalet Nørresundby Aps, Dyreklinik Centrum Aps, Dyreklinikken Nørresundby Aps, Dyrenes Sundhedscenter Aps, Dyrenesbutik.Dk Aps, Dyrlæge Bastholm Aps, Dyrlægevagten Århus Aps, Familiedyrlægerne Aps, Frederiksværk Dyrehospital Aps, Hasselager Dyreklinik Aps, Nørresundby Dyrehopital Aps, Nørresundby Dyreklinik Aps, Rynkeby Dyreklinik Aps, Tranbjerg Dyrehospital Aps, Tranbjerg Dyreklinik Aps, Østergaards Dyrehospital Aps, Østergaards Dyreklinik Aps, Virklund Dyreklinik Aps Vis mere |
CVR | 34897778 |
Adresse | Marielundvej 46E, 1 th, 2730 Herlev |
Branche | Dyrlægers aktiviteter [750000] |
Web | www.anicura.dk |
Etableret | 27-12-2012 (12 år) |
Første regnskabsperiode | 27-12-2012 til 31-12-2013 |
Virksomhedsform | Anpartsselskab |
Antal ansatte | 551 (årsværk:442) |
Reklamebeskyttelse | Nej |
Revisor | Pricewaterhousecoopers Statsautoriseret Revisionspartnerselskab siden 01-11-2019 |
Regnskabsperiode | 01-01 til 31-12 |
Selskabskapital | 80.000 DKK |
Vedtægter seneste | 30-08-2024 |
Medlem af brancherne
- Dyrlægers aktiviteter [750000]NACE6 indeholdende 973 virk.
- Dyrlægers aktiviteter [750]NACE3 indeholdende 973 virk.
- Dyrlægers aktiviteter [75]NACE2 indeholdende 973 virk.
- Liberale, videnskabelige og tekniske aktiviteter [N]NACE1 indeholdende 87.989 virk.
Formål
Selskabets formål er, direkte eller indirekte at drive virksomhed med kvalificeret dyreomsorg, sælge produkter og tjenester relateret til dyreomsorg, yde tjenester til andre selskaber i koncernen først og fremmest vedrørende administration, styring, juridisk rådgivning og markedsføring samt at drive anden virksomhed, der står i forbindelse hermed.
Regnskab
2023 | 2022 | 2021 | |
---|---|---|---|
Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
Omsætning | 434.846 - | - - | - - |
Bruttofortjeneste | 229.316 +17% | 195.989 - | -11.134 - |
Årets resultat | 3.834 - | -30.657 - | -33.976 - |
Egenkapital | 271.118 -1% | 273.116 +1.324% | 19.185 -58% |
Balance | 341.466 -6% | 365.042 -25% | 486.503 +15% |
Ledelsesberetning sammendrag
Ledelsesberetning
Key activitiesThe Group's primary activity is, directly or indirectly, to operate a business providing qualified animal care, to sell products and services related to animal care, to provide services to other companies within the AniCura Group primarily concerning administration, management, and marketing, as well as to engage in other business activities related thereto.Developments in operations and financial positionThe Group's income statement for 2023 shows a loss of TDKK 25,496, and the Group's balance sheet as of December 31, 2023, shows equity of TDKK 229,784.This year has not been in line with expectations as we anticipated revenue growth which did not materialize at the expected level. Due to fluctuations in the market which have changed the behavior of the costumers. The lower revenue has been offset by cost management across the profit and loss.We still believe in investing in our associates and increase the level of competences to increase the level of veterinary care for pets and the people who loves them, will generate a reliable organic growth.AniCura ApS merged with its subsidiaries AniCura Københavns Dyrehospital ApS and AniCura KBH Dyrehospital Komplementarselskab ApS on 4 and 5 December 2023, with AniCura ApS as the continuing company.The mergers were conducted to simplify the Group’s administration and improve the efficiency of our processes.The mergers had no impact on the daily operations or employees, and the number of employees remained unchanged after the merger.The accounting treatment of the mergers is described in note 1.Special risks - operating risks and financial risksThe Group is exposed to financial risk relating to foreign currency. The risk is relating to the increase collaboration between Denmark and Norway and sales and purchases in EUR and SEK in addition. The risk is there for limited and is not hedged; However, Management assesses the exposure on a continuous basis.The Group is not exposed from other financial or commercial risks, which is uncommon for the industry.Intangible key resourcesThe employees constitute a very important asset for the Group. The Group operates in a very competitive market and great emphasis is placed on recruiting and retaining the best employees.Focus is on the continued development and training of the employees via ongoing feedback on performance and by offering relevant education to the employees.Targets and expectations for the year aheadIn 2024 net sales are expected to grow as planned with 6.0%. Obviously, the business context remains volatile, especially when it comes to our inflation and the aim is to remain in good control of expenses. The expectation for 2024 is to improve net profit/loss in the range of DKK 0 to 25 million compared to 2023.Subsequent eventsNo events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.Generalforsamlingsdato: 14-06-2024